Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics?

Lina Maria Ellegård1, Jens Dietrichson2, Anders Anell3

  • 1Department of Economics, Lund University, Lund, Sweden.

Health Economics
|July 8, 2017
PubMed

Insights

Pay-for-performance (P4P) incentives successfully encouraged primary care physicians to prescribe narrow-spectrum antibiotics for pediatric respiratory tract infections (RTI). This intervention improved antibiotic stewardship without increasing overall prescription rates.

Area of Science:

  • Public Health
  • Health Economics
  • Infectious Diseases

Background:

  • Antibiotic resistance is a critical global health challenge.
  • Inappropriate antibiotic use, particularly for respiratory tract infections (RTI), contributes significantly to resistance.
  • Primary care physicians' prescribing habits are a key target for interventions.

Purpose of the Study:

  • To evaluate the impact of pay-for-performance (P4P) on primary care physicians' antibiotic prescribing choices.
  • To determine if P4P can promote the use of narrow-spectrum antibiotics for pediatric RTI.
  • To assess whether P4P influences overall antibiotic prescription volume.

Main Methods:

  • A difference-in-differences analysis was employed.
  • Register data on all antibiotic purchases for RTI in Sweden (2006-2013) were utilized.
  • The study compared 8 healthcare authorities that adopted P4P with control groups.

Main Results:

  • P4P significantly increased the proportion of narrow-spectrum antibiotics prescribed for pediatric RTI.
  • No evidence suggests physicians increased overall antibiotic prescriptions to game the P4P system.
  • The findings indicate P4P is an effective tool for antibiotic stewardship.

Conclusions:

  • Pay-for-performance can be a successful strategy to improve antibiotic prescribing practices in primary care.
  • Targeting antibiotic choice, rather than volume, is achievable with P4P incentives.
  • Interventions like P4P are crucial for combating antibiotic resistance globally.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Antibiotic Selection00:57

Antibiotic Selection

Overview
60.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
232
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.3K